-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RhIGV5QS57GO0hqfapkKdiL5tkw+wVswCrW7nwEhlTRpbbD0H0z1XSgYZynL/fBT S1rT4gqH5C6zPLqumQjmzw== 0001104659-09-011575.txt : 20090223 0001104659-09-011575.hdr.sgml : 20090223 20090223195255 ACCESSION NUMBER: 0001104659-09-011575 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090211 FILED AS OF DATE: 20090223 DATE AS OF CHANGE: 20090223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARTIN JEFFREY L CENTRAL INDEX KEY: 0001456531 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 09629302 BUSINESS ADDRESS: BUSINESS PHONE: 301-986-0701 MAIL ADDRESS: STREET 1: HANGER ORTHOPEDIC GROUP, INC. STREET 2: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 3 1 a3.xml 3 X0203 3 2009-02-11 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001456531 MARTIN JEFFREY L TWO BETHESDA METRO CENTER SUITE 1200 BETHESDA MD 20814 0 1 0 0 Pres. Innovative Neurotronics Common Stock 29810 D Incentive Stock Option 16.75 2003-09-17 2012-09-16 Common Stock 4000 D Includes vested and unvested restricted shares from previous awards of restricted stock to the reporting person. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. This option vested over a four-year period from the date of grant and is now fully vested. /s/ Teri L. Champ attorney-in-fact 2009-02-23 EX-24 2 ex-24.htm EX-24

Exhibit 24

 

POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS that the person whose signature appears below hereby constitutes and appoints Jay Freedman, Thomas James, Arthur Bill, Thomas Hartman, Timothy Maples, Christian Fonss, Mariel Estigarribia, Matthew Bronson, Teri Champ and Jared Cook, or any one of them, such person’s true and lawful attorney-in-fact and agent, with full power of substitution and revocation, for such person and in such person’s name, place and stead, to sign any Report on Form 3, Form 4 or Form 5, in any such case with respect to his or her beneficial ownership of shares of Hanger Orthopedic Group, Inc. common stock (“Common Stock”), and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission and any exchange or similar system for trading on which the Common Stock is or hereafter becomes listed or qualified for trading or quoting.

 

 

Dated: February 12, 2009

 

 

 

/s/ Jeffrey L. Martin

 

Jeffrey L. Martin

 

 -----END PRIVACY-ENHANCED MESSAGE-----